The latest price target for NOV (NYSE:NOV) was reported by Morgan Stanley on September 16, 2024. The analyst firm set a price target for $23.00 expecting NOV to rise to within 12 months (a possible 39.99% upside). 20 analyst firms have reported ratings in the last year.

The latest analyst rating for NOV (NYSE:NOV) was provided by Morgan Stanley, and NOV maintained their overweight rating.

The last upgrade for NOV Inc happened on December 8, 2023 when JP Morgan raised their price target to $25. JP Morgan previously had a neutral for NOV Inc.

The last downgrade for NOV Inc happened on January 16, 2024 when Benchmark changed their price target from N/A to N/A for NOV Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NOV, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NOV was filed on September 16, 2024 so you should expect the next rating to be made available sometime around September 16, 2025.

While ratings are subjective and will change, the latest NOV (NOV) rating was a maintained with a price target of $25.00 to $23.00. The current price NOV (NOV) is trading at is $16.43, which is out of the analyst’s predicted range.